About Bluefish Pharmaceuticals
Bluefish Pharmaceuticals is a company based in Stockholm (Sweden) founded in 2005. Bluefish Pharmaceuticals has raised $21.67 million across 5 funding rounds from investors including Catella, NXT2B and Varenne. The company has 81 employees as of April 05, 2024. Bluefish Pharmaceuticals offers products and services including Generic Medicines and Partnering Services.
- Headquarter Stockholm, Sweden
- Employees 81 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bluefish Pharmaceuticals Private Limited
- Date of Incorporation 28 Sep, 2006
- Jurisdiction Whitefield Ashram Road Bangalore, Karnataka, India
-
Annual Revenue
$2.51 M (USD)17.8as on Mar 31, 2022
-
Net Profit
$165.24 K (USD)61.46as on Mar 31, 2022
-
EBITDA
$374.33 K (USD)58.93as on Mar 31, 2022
-
Total Equity Funding
$21.67 M (USD)
in 5 rounds
-
Latest Funding Round
$3.3 M (USD), Series B
May 22, 2014
-
Investors
Catella
& 2 more
-
Employee Count
81
as on Apr 05, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bluefish Pharmaceuticals
Bluefish Pharmaceuticals offers a comprehensive portfolio of products and services, including Generic Medicines and Partnering Services.
Generic medicines are manufactured for various therapeutic areas, with bioequivalence established to originator products to ensure affordability and efficacy.
Partnerships are provided with development and manufacturing experts to optimize product portfolios and supply chains in the pharmaceutical sector.
People of Bluefish Pharmaceuticals
Unlock access to complete
Funding Insights of Bluefish Pharmaceuticals
Bluefish Pharmaceuticals has successfully raised a total of $21.67M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $3.3 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bluefish Pharmaceuticals
Bluefish Pharmaceuticals has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Catella, NXT2B and Varenne.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NXT2B is recognized as a venture capital investment firm.
|
Locked | Locked | Locked | |
|
Companies are supported by Varenne in their growth journey.
|
Locked | Locked | Locked | |
|
M&A strategic advisory and real estate services are provided globally.
|
Locked | Locked | Locked |
Investor details for Bluefish Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bluefish Pharmaceuticals
Investment portfolio details for Bluefish Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bluefish Pharmaceuticals
Detailed financials for Bluefish Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bluefish Pharmaceuticals Comparisons
Peer comparison for Bluefish Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bluefish Pharmaceuticals
Detailed competitors of Bluefish Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bluefish Pharmaceuticals
Complete news archive for Bluefish Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bluefish Pharmaceuticals
Bluefish Pharmaceuticals was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Bluefish Pharmaceuticals is headquartered in Stockholm, Sweden.
Bluefish Pharmaceuticals is a funded company, having raised a total of $21.67M across 5 funding rounds to date.
As of Apr 05, 2024, the latest employee count at Bluefish Pharmaceuticals is 81.
Annual revenue of Bluefish Pharmaceuticals is $2.51M as on Mar 31, 2022.
Manufacturer of affordable generic pharmaceutical products. It focuses on developing and marketing bioequivalent versions of off-patent medications. The company partners with manufacturing experts to ensure rigorous quality standards are met throughout the product lifecycle, from development to distribution. Its marketing strategy emphasizes organic growth and market-specific approaches, targeting various healthcare institutions. The products are derived from well-established generic substances, with extensive research supporting their efficacy and safety. This approach minimizes development time and optimizes investments, resulting in a cost-effective product portfolio.
Bluefish Pharmaceuticals offers Generic Medicines and Partnering Services.